Morgan Stanley Upgrades ACM Research to Overweight
Morgan Stanley analyst Charlie Chan upgrades ACM Research (NASDAQ:ACMR) from Underweight to Overweight.
Piper Sandler Upgrades Mercantile Bank to Overweight, Raises Price Target to $40
Piper Sandler analyst Brandan Nosal upgrades Mercantile Bank (NASDAQ:MBWM) from Neutral to Overweight and raises the price target from $38 to $40.
Credit Suisse Upgrades Esperion Therapeutics to Neutral, Raises Price Target to $7
Credit Suisse analyst Judah Frommer upgrades Esperion Therapeutics (NASDAQ:ESPR) from Underperform to Neutral and raises the price target from $6.5 to $7.
Keybanc Upgrades Kimbell Royalty Partners to Overweight, Announces $21 Price Target
Keybanc analyst Tim Rezvan upgrades Kimbell Royalty Partners (NYSE:KRP) from Sector Weight to Overweight and announces $21 price target.
HashiCorp Likely To Become Anchor Vendor Across Infrastructure And Security Aided By Multi-Cloud Adoption, Analyst Says
Needham analyst Alex Henderson upgrades HashiCorp Inc (NASDAQ:HCP) from Hold to Buy with a $39 price target. Henderson thinks Street estimates for…
Goldman Sachs Upgrades iQIYI to Buy, Announces $10 Price Target
Goldman Sachs analyst Lincoln Kong upgrades iQIYI (NASDAQ:IQ) from Neutral to Buy and announces $10 price target.
Redburn Partners Upgrades Monster Beverage to Buy, Announces $120 Price Target
Redburn Partners analyst Charlie Higgs upgrades Monster Beverage (NASDAQ:MNST) from Neutral to Buy and announces $120 price target.
RBC Capital Upgrades Enerflex to Outperform, Raises Price Target to C$16
RBC Capital analyst Keith Mackey upgrades Enerflex (TSX:EFX) from Sector Perform to Outperform and raises the price target from C$12 to C$16.
UBS Upgrades Emerson Electric to Buy, Lowers Price Target to $97
UBS analyst Chris Snyder upgrades Emerson Electric (NYSE:EMR) from Neutral to Buy and lowers the price target from $100 to $97.
Morgan Stanley Upgrades Ternium to Overweight, Raises Price Target to $52
Morgan Stanley analyst Carlos De Alba upgrades Ternium (NYSE:TX) from Equal-Weight to Overweight and raises the price target from $34 to $52.